Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, 2100 Blegdamsvej 9, Copenhagen, Denmark.
Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 København N, Copenhagen, Denmark.
Eur Heart J. 2018 Jan 7;39(2):102-110. doi: 10.1093/eurheartj/ehx491.
We aimed to study survival and causes of death in patients with ST-elevation acute coronary syndrome (STE-ACS) with and without obstructive coronary artery disease (CAD).
We included 4793 consecutive patients with STE-ACS triaged for acute coronary angiography at a large cardiac invasive centre (2009-2014). Of these, 88% had obstructive CAD (stenosis ≥50%), 6% had non-obstructive CAD (stenosis 1-49%), and 5% had normal coronary arteries. Patients without obstructive CAD were younger and more often female with fewer cardiovascular risk factors. Median follow-up time was 2.6 years. Compared with patients with obstructive CAD, the short-term hazard of death (≤30 days) was lower in both patients with non-obstructive CAD [hazard ratio (HR) 0.49, 95% confidence interval (CI) 0.27-0.89, P = 0.018] and normal coronary arteries (HR 0.31, 95% CI 0.11-0.83, P = 0.021). In contrast, the long-term hazard of death (>30 days) was similar in patients with non-obstructive CAD (HR 1.15, 95% CI 0.77-1.72, P = 0.487) and higher in patients with normal coronary arteries (HR 2.44, 95% CI 1.58-3.76, P < 0.001), regardless of troponin levels. Causes of death were cardiovascular in 70% of patients with obstructive CAD, 38% with non-obstructive CAD, and 32% with normal coronary arteries. Finally, patients without obstructive CAD had lower survival compared with an age and sex matched general population.
STE-ACS patients without obstructive CAD had a long-term risk of death similar to or higher than patients with obstructive CAD. Causes of death were less often cardiovascular. This suggests that STE-ACS patients without obstructive CAD warrant medical attention and close follow-up.
本研究旨在探讨伴有和不伴有阻塞性冠状动脉疾病(CAD)的 ST 段抬高型急性冠状动脉综合征(STE-ACS)患者的生存和死亡原因。
我们纳入了在一家大型心脏介入中心进行急性冠状动脉造影分诊的 4793 例连续 STE-ACS 患者(2009-2014 年)。其中,88%的患者有阻塞性 CAD(狭窄≥50%),6%的患者有非阻塞性 CAD(狭窄 1-49%),5%的患者有正常冠状动脉。无阻塞性 CAD 的患者年龄较小,女性较多,心血管危险因素较少。中位随访时间为 2.6 年。与阻塞性 CAD 患者相比,非阻塞性 CAD(风险比 [HR] 0.49,95%置信区间 [CI] 0.27-0.89,P=0.018)和正常冠状动脉患者(HR 0.31,95%CI 0.11-0.83,P=0.021)的短期死亡风险(≤30 天)较低。相反,非阻塞性 CAD(HR 1.15,95%CI 0.77-1.72,P=0.487)和正常冠状动脉患者(HR 2.44,95%CI 1.58-3.76,P<0.001)的长期死亡风险相似,而不管肌钙蛋白水平如何。70%的阻塞性 CAD 患者、38%的非阻塞性 CAD 患者和 32%的正常冠状动脉患者的死亡原因为心血管疾病。最后,无阻塞性 CAD 的 STE-ACS 患者的生存率低于年龄和性别匹配的一般人群。
无阻塞性 CAD 的 STE-ACS 患者的长期死亡风险与阻塞性 CAD 患者相似或更高。死亡原因较少为心血管疾病。这表明,无阻塞性 CAD 的 STE-ACS 患者需要医疗关注和密切随访。